MeSH term
Frequency | Condition_Probility | Adolescent | 8 | 0.0 |
Adult | 26 | 0.0 |
Aged | 7 | 0.0 |
Base Sequence | 5 | 0.0 |
Child | 11 | 0.0 |
Child, Preschool | 3 | 0.0 |
Female | 49 | 0.0 |
Humans | 125 | 0.0 |
Male | 51 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 41 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Alleles | 22 | 0.0 |
Blood Group Antigens/*genetics | 10 | 9.0 |
Chi-Square Distribution | 3 | 0.0 |
Cluster Analysis | 3 | 1.0 |
Ethnic Groups/*genetics | 9 | 4.0 |
Gene Frequency | 51 | 1.0 |
Haplotypes | 5 | 0.0 |
Phenotype | 46 | 0.0 |
*Polymorphism, Genetic | 45 | 0.0 |
Comparative Study | 23 | 0.0 |
English Abstract | 30 | 0.0 |
*Genetic Markers | 15 | 4.0 |
Treatment Outcome | 2 | 0.0 |
ABO Blood-Group System/*genetics | 2 | 4.0 |
Acid Phosphatase/genetics | 6 | 18.0 |
Erythrocytes/*enzymology | 24 | 4.0 |
Esterases/genetics | 2 | 11.0 |
Lactoylglutathione Lyase/genetics | 12 | 27.0 |
Phosphoglucomutase/genetics | 10 | 21.0 |
Russia | 10 | 10.0 |
*Carboxylesterase | 8 | 7.0 |
*Gene Pool | 7 | 36.0 |
Geography | 2 | 3.0 |
Lactoylglutathione Lyase/*genetics | 24 | 57.0 |
Animals | 6 | 0.0 |
Mice | 3 | 0.0 |
Homozygote | 4 | 0.0 |
Middle Aged | 15 | 0.0 |
Ethnic Groups/genetics | 2 | 1.0 |
Enzymes/*genetics | 7 | 16.0 |
Genetic Markers/*genetics | 3 | 2.0 |
*Genetics, Population | 14 | 3.0 |
Italy | 6 | 0.0 |
Polymorphism, Genetic/*genetics | 7 | 0.0 |
Chromosome Mapping | 14 | 0.0 |
Data Interpretation, Statistical | 2 | 0.0 |
Haptoglobins/*genetics | 3 | 7.0 |
*Phenotype | 2 | 0.0 |
Genetic Markers | 16 | 0.0 |
Sampling Studies | 2 | 1.0 |
Spain | 5 | 1.0 |
*Variation (Genetics) | 3 | 0.0 |
Africa/ethnology | 2 | 4.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
Ecuador | 2 | 18.0 |
Emigration and Immigration | 4 | 8.0 |
Enzymes/genetics | 6 | 18.0 |
*Gene Frequency | 17 | 3.0 |
Blood Proteins/*genetics | 15 | 9.0 |
Factor Analysis, Statistical | 2 | 5.0 |
Gene Frequency/*genetics | 4 | 2.0 |
Heterozygote Detection | 2 | 0.0 |
Siberia | 3 | 7.0 |
ABO Blood-Group System/genetics | 5 | 11.0 |
Acid Phosphatase/blood/genetics | 2 | 28.0 |
Haptoglobins/genetics | 8 | 16.0 |
Heterozygote | 5 | 0.0 |
Protease Inhibitors/metabolism | 2 | 6.0 |
Transferrin/genetics | 8 | 16.0 |
Vitamin D-Binding Protein/genetics | 5 | 18.0 |
Brazil | 2 | 0.0 |
Complement 3/genetics | 3 | 8.0 |
Mediterranean Islands | 2 | 28.0 |
Case-Control Studies | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Gene Frequency/genetics | 4 | 0.0 |
Blood Group Antigens/genetics | 5 | 8.0 |
Adenosine Deaminase/genetics | 3 | 13.0 |
Adenylate Kinase/genetics | 4 | 16.0 |
Carbonic Anhydrases/genetics | 2 | 22.0 |
Glucosephosphate Dehydrogenase/genetics | 3 | 3.0 |
Infant | 2 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Polymorphism, Genetic | 22 | 0.0 |
Prognosis | 2 | 0.0 |
European Continental Ancestry Group/*genetics | 4 | 1.0 |
Europe | 2 | 0.0 |
Africa, Western | 2 | 9.0 |
Blood Proteins/genetics | 5 | 8.0 |
Erythrocytes/enzymology | 13 | 3.0 |
Carboxylic Ester Hydrolases/blood/genetics | 2 | 40.0 |
India | 7 | 2.0 |
Lactoylglutathione Lyase/blood/genetics | 3 | 75.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
*Chromosomes, Human, Pair 6 | 3 | 1.0 |
European Continental Ancestry Group/genetics | 5 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Genes, Recessive | 2 | 0.0 |
Pedigree | 11 | 0.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
*Indians, South American | 2 | 8.0 |
Australia | 2 | 1.0 |
Lod Score | 4 | 0.0 |
Asian Continental Ancestry Group/*genetics | 3 | 0.0 |
Language | 2 | 8.0 |
Carboxylic Ester Hydrolases/genetics | 5 | 16.0 |
Genetic Markers/genetics | 4 | 0.0 |
Isoenzymes/genetics | 2 | 0.0 |
Phosphogluconate Dehydrogenase/genetics | 4 | 15.0 |
*Chromosome Mapping | 3 | 0.0 |
Isoenzymes/*genetics | 2 | 0.0 |
HLA Antigens/*genetics | 9 | 1.0 |
Linkage (Genetics) | 12 | 0.0 |
*Jews | 3 | 6.0 |
South Africa | 3 | 2.0 |
African Continental Ancestry Group | 2 | 0.0 |
Denmark | 2 | 1.0 |
Histocompatibility Testing | 2 | 0.0 |
Recombination, Genetic | 5 | 0.0 |
Complement Factor B/genetics | 2 | 2.0 |
*Ethnic Groups | 6 | 5.0 |
Oxidoreductases/*genetics | 2 | 2.0 |
China | 3 | 0.0 |
Complement 4/*genetics | 2 | 1.0 |
Complement Factor B/*genetics | 2 | 1.0 |
*Major Histocompatibility Complex | 4 | 1.0 |
Hemoglobins/genetics | 4 | 16.0 |
European Continental Ancestry Group | 2 | 0.0 |
Lyases/*genetics | 24 | 48.0 |
*Linkage (Genetics) | 8 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Factor XIII/*genetics | 2 | 12.0 |
*Genes, Structural | 3 | 0.0 |
Transglutaminases | 2 | 25.0 |
*Alleles | 2 | 0.0 |
Genetics, Population | 5 | 1.0 |
Enzymes/blood/*genetics | 3 | 50.0 |
HLA Antigens/genetics | 5 | 1.0 |
HLA-DR Antigens | 4 | 1.0 |
Histocompatibility Antigens Class II/genetics | 3 | 2.0 |
France | 2 | 0.0 |
Genotype | 4 | 0.0 |
*Chromosomes, Human, 6-12 and X | 3 | 2.0 |
Sex Factors | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Consanguinity | 2 | 0.0 |
Israel | 2 | 1.0 |
Belgium | 2 | 3.0 |
Isoenzymes/blood/*genetics | 3 | 13.0 |
Lactoylglutathione Lyase/blood/*genetics | 8 | 88.0 |
Chromosomes, Human, 6-12 and X | 2 | 4.0 |
Germany, West | 3 | 6.0 |
